Free Research Preview. DrugChatter may produce inaccurate information.
Save time and get answers to complex questions with AI chat
Lupron eu patent expiry?How does insurance affect nivolumab's treatment cost?Biosimilars of mylotarg?When does aimovig go off patent?Eculizumab patent 1996?
See the DrugPatentWatch profile for Caspofungin
Caspofungin (brand name Cancidas) was approved by the U.S. Food and Drug Administration (FDA) on July 21, 2001. [1]
The FDA approval date is the day the FDA officially granted marketing authorization for caspofungin for its approved indications under the original application. That date is often used for later calculations tied to exclusivity and patent timelines, though those are governed by separate legal time periods. [1]
DrugPatentWatch.com tracks approval and patent/exclusivity-related information for drugs, including caspofungin. [1]
[1] https://www.drugpatentwatch.com/p/cancidas
Other Questions About Caspofungin :